Skip to main content
Publications
Gomez-Roig MD, Pascal R, Cahuana MJ, Garcia-Algar O, Sebastiani G, Andreu-Fernandez V, Martinez L, Rodriguez G, Iglesia I, Ortiz-Arrabal O, Mesa MD, Cabero MJ, Guerra L, Llurba E, Dominguez C, Zanini MJ, Foraster M, Larque E, Cabanas F, Lopez-Azorin M, Perez A, Loureiro B, Pallas-Alonso CR, Escuder-Vieco D, Vento M. Environmental exposure during pregnancy: influence on prenatal development and early life: a comprehensive review. Fetal Diagn Ther. 2021;48(4):245-57. doi: 10.1159/000514884
Goyal RK, Cuyun Carter G, Nagar SP, Nash Smyth E, Price GL, Parikh RC, Huang YJ, Li L, Davis KL, Kaye JA. Treatment patterns, adverse events, and direct and indirect economic burden in a privately insured population of patients with HR+/HER2- metastatic breast cancer in the United States. Expert Rev Pharmacoecon Outcomes Res. 2021;21(4):699-710. doi: 10.1080/14737167.2020.1804871
Dubner SJ, Teutsch C, Huisman MV, Diener H-C, Halperin J, Rothman KJ, Ma C-S, Chuquiure-Valenzuela E, Bergler-Klein J, Zint K, Franca LR, Lu S, Paquette M, Lip GYH. Characteristics and 2-year outcomes of dabigatran treatment in patients with heart failure and atrial fibrillation: GLORIA-AF. ESC Heart Fail. 2020 Oct;7(5):2679-89. doi: 10.1002/ehf2.12857